Tests BPC 157 (IM and intragastric) for acute and chronic gastric ulcer models in rats using established inducing agents (pylorus ligation, ethanol, acetic acid). Both IM and intragastric BPC 157 (400–800 ng/kg) significantly reduced ulcer area and inhibited ulcer formation 45–65% across all models. IM administration outperformed intragastric delivery, with efficacy exceeding famotidine (H2 blocker) in all three acute models. In chronic acetate-induced ulcers, BPC 157 promoted epithelial regeneration and granulation tissue. Systematic comparison across models confirms BPC 157 as a potent anti-ulcer agent at sub-microgram doses.
Xue, Xiao-Chang; Wu, Yong-Jie; Gao, Ming-Tang; Li, Wen-Guang; Zhao, Ning; Wang, Zeng-Lu; Bao, Chun-Jie; Yan, Zhen; Zhang, Ying-Qi